NDC 63672-0002-1 - Simvastatin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63672-0002
Requested NDC
63672-0002-1
Package NDCs from labels
63672-0002-1, 63672-0002-3
Manufacturer
Synthon Pharmaceuticals, Inc.
Effective date
2008-01-23
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
SIMVASTATIN ORALLY DISINTEGRATING TABLETS (SIMVASTATIN)Synthon Pharmaceuticals, Inc.2008-01-23HUMAN PRESCRIPTION DRUG LABELING

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63672-0002-1Simvastatin30 in 1 BOTTLETABLET, ORALLY DISINTEGRATING301
63672-0002-3Simvastatin90 in 1 BOTTLETABLET, ORALLY DISINTEGRATING901

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63672-0002SIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]12 package rows20080205_34B56F73-BEA4-4265-8B2A-C57520CF8E70.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SimvastatinACTIVE INGREDIENTAGG2FN16EVSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
SimvastatinACTIVE MOIETYAGG2FN16EVSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
butylated hydroyanisoleINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
celluloseINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
crospovidoneINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
glyceryl behenateINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
hydroxypropyl celluloseINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
iron oxide redINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
iron oxide yellowINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
mint mentholINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
povidoneINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
silicified microcrystallineINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1
sucraloseINACTIVE INGREDIENTSIMVASTATIN (SIMVASTATIN) TABLET, ORALLY DISINTEGRATING [SYNTHON PHARMACEUTICALS, INC.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
577C735F-1A17-3675-7016-6AF3E48680A234B56F73-BEA4-4265-8B2A-C57520CF8E702008-01-23Warnings, Adverse reactionsExact identifier
spl id: 577C735F-1A17-3675-7016-6AF3E48680A2
spl set id: 34B56F73-BEA4-4265-8B2A-C57520CF8E70

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.